Uncovering the complexity of structural variants in four individuals with autism spectrum disorder.
Dada Sarah, Dixon Katherine, Akbari Vahid, Grisdale Cameron J, Calli Kristina, Martell Sally, Reisle Caralyn, Lillico-Ouachour Amanda, Lewis M E Suzanne, Jones Steven J M
What this study means for families
Researchers used a new type of genetic testing on four people with autism to find large genetic changes that regular testing might miss. This advanced testing found complex genetic variants and could examine how genes are turned on or off. The authors believe this approach could lead to better diagnosis and more personalized treatments for autism, though this was a very small study.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Research summary
This study examined structural variants (large genetic changes) in four individuals with autism spectrum disorder using advanced long-read DNA sequencing technology. The researchers found that this newer sequencing method could detect complex genetic variants that standard short-read sequencing missed, particularly in repetitive regions of the genome. The technology also allowed examination of DNA methylation patterns and precise identification of variant breakpoints. The authors suggest this approach could improve precision diagnosis and lead to more individualized treatments, though the study was limited to four cases and represents preliminary research into this methodology.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Key findings
- 1
Long-read sequencing detected structural variants not visible with standard short-read sequencing
Confidence: moderateRelevance: Could improve genetic diagnostic capabilities for autism - 2
The technology allowed precise identification of variant breakpoints and methylation patterns
Confidence: moderateRelevance: May provide insights into molecular mechanisms underlying autism - 3
This approach may contribute to precision diagnosis and individualized treatment
Confidence: limitedRelevance: Potential for personalized medicine approaches in autism
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Clinical implications
This methodology shows promise for improving genetic diagnosis in autism by detecting previously missed structural variants. However, clinical implementation would require validation in larger studies and assessment of cost-effectiveness compared to standard genetic testing approaches.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Limitations
Very small sample size (4 individuals). No comparison group provided. Study represents preliminary methodology exploration rather than definitive clinical validation. Clinical utility and cost-effectiveness not established.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Original abstract
Autism spectrum disorder (ASD) is an increasingly recognized childhood developmental disorder. Despite extensive study, causal variants and molecular diagnosis remain elusive. There is both heterogeneity of the phenotype, as well as the genetic landscape associated with phenotype, which includes both inherited and de novo mutations. Currently, diagnosis is complex and behaviourally based, oftentimes occurring years after the ideal 1-2 years of age.
Structural variants (SVs) are large and sometimes complex genomic variants that are likely underrepresented contributors to ASD due to the limitations of short-read DNA sequencing, such as alignment in repetitive regions and regions with GC bias. Here, we performed long-read sequencing (LRS) on four individuals with autism spectrum disorder to delineate SV complexity and determine precise breakpoints for SVs, which was not possible with short-read whole-genome sequencing (SRS). We use LRS to interrogate the methylation pattern associated with the SVs and phase the SV haplotypes to further clarify their contribution to disorder. LRS allows insight into the genome and methylome that allow us to uncover variant complexity and contribution that was previously unseen with SRS.
Ultimately, this furthers precision diagnosis and contributes to individualized treatment for affected individuals and their families within the clinic.
Evidence Grade
emerging
Grade assigned by AutismInsights based on study type and published abstract.
Study Details
- Journal
- Genome
- Year
- 2025
- PMID
- 39666962
- DOI
- 10.1139/gen-2024-0121
MeSH Terms